MARGARET BROWN: Open Payments
NPI 1568601078 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 42 payments from 6 companies in 2025. Trend: 2023 $61 · 2024 $427 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $287 |
| E.R. Squibb & Sons, L.L.C. | 11 | $138 |
| Sage Therapeutics, LLC | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
Products named: FANAPT, COBENFY, ZURZUVAE, Qelbree, UZEDY.
Industry payments across MA — which companies pay providers there.
